Skip to main content

Peer Review reports

From: A Phase II study of pulse dose imatinib mesylate and weekly paclitaxel in patients aged 70 and over with advanced non-small cell lung cancer

Original Submission
8 Jun 2012 Submitted Original manuscript
5 Aug 2012 Reviewed Reviewer Report - Mark McKeage
22 Aug 2012 Reviewed Reviewer Report - Dragan Damianovich
18 Sep 2012 Author responded Author comments - Julie Bauman
Resubmission - Version 2
18 Sep 2012 Submitted Manuscript version 2
18 Sep 2012 Author responded Author comments - Julie Bauman
Resubmission - Version 3
18 Sep 2012 Submitted Manuscript version 3
18 Sep 2012 Author responded Author comments - Julie Bauman
Resubmission - Version 4
18 Sep 2012 Submitted Manuscript version 4
Publishing
2 Oct 2012 Editorially accepted
3 Oct 2012 Article published 10.1186/1471-2407-12-449

You can find further information about peer review here.

Back to article page